ReviewCell death discovery2025
Circulating tumor cells in breast cancer bone metastasis: mechanisms, clinical relevance, and future directions.
Review in Cell death discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- METTL3-YTHDF1-driven mMolecular and cellular biochemistry · 2026Article
- Longitudinal monitoring of circulating tumor cell phenotypic conversion as a predictor of late recurrence in breast cancer: a prospective feasibility study using the GenoCTC platform.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Circulating tumor cells (CTCs) play a critical role in the metastatic cascade and have emerged as promising biomarkers for cancer diagnosis, prognosis, and therapeutic monitoring. In breast cancer, CTCs mediate bone metastasis through intricate interactions with the bone microenvironment, regulating process such as homing, dormancy, reactivation, and colonization. Advances in CTC detection and characterization have deepened our understanding of their physical and biological properties, yet significant technical and biological challenges remain. This review provides a comprehensive overview of the roles of CTCs in breast cancer bone metastasis and highlighting their clinical significance, current limitations, and future applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.